Muscle and Recovery

Tissue-repair signalling in tendon, muscle and gastrointestinal models.

GHRH analogue studied for sustained elevation of growth hormone and IGF-1.

Non-selective growth-hormone secretagogue. Its best-evidenced human uses are diagnostic testing of pituitary reserve and, separately, stimulation of appetite.

Early non-selective growth-hormone secretagogue, used in humans mainly as a pituitary provocation agent for diagnostic testing rather than as a treatment.

Potent growth-hormone secretagogue, also studied for cardiac effects independent of growth hormone.

Recombinant human growth hormone — an approved medicine, sold in this category for uses it was tested for and failed.

A cell-culture reagent version of IGF-1, engineered to evade binding proteins.

Selective ghrelin receptor agonism for growth-hormone release without the cortisol and prolactin rise of older secretagogues.

A multi-compound blend combining several research peptides in one vial.

Orally active non-peptide growth-hormone secretagogue studied in sarcopenia, frailty and hip fracture recovery.

Actin-sequestering peptide fragment studied in wound healing and tissue repair models.

GHRH analogue studied for visceral adipose reduction in HIV-associated lipodystrophy.